Exact Mass: 470.1801406
Exact Mass Matches: 470.1801406
Found 196 metabolites which its exact mass value is equals to given mass value 470.1801406
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Docarpamine
Imiglitazar
C28H26N2O5 (470.18416260000004)
6-[2-hydroxy-3-methyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutyl]-5,7-dimethoxychromen-2-one
4beta-hydroxy-6-O-(p-hydroxybenzoyl)-tetrahydrolinaride|americanoside
5-[4-[2-(3-Hydroxyphenyl)ethyl]phenoxy]-6-methoxy-9,10-dihydrophenanthrene-1,2,7-triol
5-[2-(6-Hydroxy-4,7-dimethoxy-benzofuran-5-yl)-2-oxo-ethyl]-4-methoxy-6,6-dimethyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-6-ium
6-[2-hydroxy-3-methyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutyl]-5,7-dimethoxychromen-2-one
6-[2-hydroxy-3-methyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutyl]-5,7-dimethoxychromen-2-one [IIN-based: Match]
6-[2-hydroxy-3-methyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutyl]-5,7-dimethoxychromen-2-one_major
6-[2-hydroxy-3-methyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutyl]-5,7-dimethoxychromen-2-one_68.0\\%
Ala Asp Glu His
Ala Asp His Glu
Ala Glu Asp His
Ala Glu His Asp
Ala His Asp Glu
Ala His Glu Asp
Ala Met Ser Tyr
Ala Met Tyr Ser
Ala Ser Met Tyr
Ala Ser Tyr Met
Ala Tyr Met Ser
Ala Tyr Ser Met
Cys Phe Thr Thr
Cys Ser Val Tyr
Cys Ser Tyr Val
Cys Thr Phe Thr
Cys Thr Thr Phe
Cys Val Ser Tyr
Cys Val Tyr Ser
Cys Tyr Ser Val
Cys Tyr Val Ser
Asp Ala Glu His
Asp Ala His Glu
Asp Glu Ala His
Asp Glu His Ala
Asp His Ala Glu
Asp His Glu Ala
Glu Ala Asp His
Glu Ala His Asp
Glu Asp Ala His
Glu Asp His Ala
Glu Glu Gly His
Glu Glu His Gly
Glu Gly Glu His
Glu Gly His Glu
Glu His Ala Asp
Glu His Asp Ala
Glu His Glu Gly
Glu His Gly Glu
Phe Cys Thr Thr
Phe Met Ser Ser
Phe Ser Met Ser
Phe Ser Ser Met
Phe Thr Cys Thr
Phe Thr Thr Cys
Gly Glu Glu His
Gly Glu His Glu
Gly His Glu Glu
Gly Met Thr Tyr
Gly Met Tyr Thr
Gly Thr Met Tyr
Gly Thr Tyr Met
Gly Tyr Met Thr
Gly Tyr Thr Met
His Ala Asp Glu
His Ala Glu Asp
His Asp Ala Glu
His Asp Glu Ala
His Glu Ala Asp
His Glu Asp Ala
His Glu Glu Gly
His Glu Gly Glu
His Gly Glu Glu
His Asn Asn Ser
His Asn Ser Asn
His Ser Asn Asn
Met Ala Ser Tyr
Met Ala Tyr Ser
Met Phe Ser Ser
Met Gly Thr Tyr
Met Gly Tyr Thr
Met Ser Ala Tyr
Met Ser Phe Ser
Met Ser Ser Phe
Met Ser Tyr Ala
Met Thr Gly Tyr
Met Thr Tyr Gly
Met Tyr Ala Ser
Met Tyr Gly Thr
Met Tyr Ser Ala
Met Tyr Thr Gly
Asn His Asn Ser
Asn His Ser Asn
Asn Asn His Ser
Asn Asn Ser His
Asn Ser His Asn
Asn Ser Asn His
Ser Ala Met Tyr
Ser Ala Tyr Met
Ser Cys Val Tyr
Ser Cys Tyr Val
Ser Phe Met Ser
Ser Phe Ser Met
Ser His Asn Asn
Ser Met Ala Tyr
Ser Met Phe Ser
Ser Met Ser Phe
Ser Met Tyr Ala
Ser Asn His Asn
Ser Asn Asn His
Ser Ser Phe Met
Ser Ser Met Phe
Ser Val Cys Tyr
Ser Val Tyr Cys
Ser Tyr Ala Met
Ser Tyr Cys Val
Ser Tyr Met Ala
Ser Tyr Val Cys
Thr Cys Phe Thr
Thr Cys Thr Phe
Thr Phe Cys Thr
Thr Phe Thr Cys
Thr Gly Met Tyr
Thr Gly Tyr Met
Thr Met Gly Tyr
Thr Met Tyr Gly
Thr Thr Cys Phe
Thr Thr Phe Cys
Thr Tyr Gly Met
Thr Tyr Met Gly
Val Cys Ser Tyr
Val Cys Tyr Ser
Val Ser Cys Tyr
Val Ser Tyr Cys
Val Tyr Cys Ser
Val Tyr Ser Cys
Tyr Ala Met Ser
Tyr Ala Ser Met
Tyr Cys Ser Val
Tyr Cys Val Ser
Tyr Gly Met Thr
Tyr Gly Thr Met
Tyr Met Ala Ser
Tyr Met Gly Thr
Tyr Met Ser Ala
Tyr Met Thr Gly
Tyr Ser Ala Met
Tyr Ser Cys Val
Tyr Ser Met Ala
Tyr Ser Val Cys
Tyr Thr Gly Met
Tyr Thr Met Gly
Tyr Val Cys Ser
Tyr Val Ser Cys
4-(5,7-Dimethoxy-2-oxo-2H-chromen-6-yl)-3-hydroxy-2-methyl-2-butanyl ?-D-glucopyranoside
N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-yl]thio]benzamide
Docarpamine
D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist
Imiglitazar
C28H26N2O5 (470.18416260000004)
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C154291 - Peroxisome Proliferator-Activated Receptor Agonist
O-(3-O-beta-D-galactosyl-N-acetyl-alpha-D-galactosaminyl)-L-serine
A serine derivative that is L-serine having a 3-O-beta-D-galactosyl-N-acetyl-alpha-D-galactosaminyl moiety attached to the side-chain oxygen.
N-(5-chloro-1,3-benzodioxol-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-amine
C24H27ClN4O4 (470.17207320000006)
(E)-4-[4-(5-methyl-2-phenyl-4-oxazolylmethoxy)benzyloxyimino]-4-phenylbutyric acid
C28H26N2O5 (470.18416260000004)
5-[2-(6-Hydroxy-4,7-dimethoxy-1-benzofuran-5-yl)-2-oxoethyl]-4-methoxy-6,6-dimethyl-5,6,7,8-tetrahydro[1,3]dioxolo[4,5-g]isoquinolin-6-ium
[4-[(2-Chlorophenyl)methyl]-1-piperazinyl]-(6,8-dimethyl-2-pyridin-4-yl-4-quinolinyl)methanone
methyl 3-[3-[4-(3-chlorophenyl)piperazin-1-yl]propanoylamino]-4-methoxy-1H-indole-2-carboxylate
C24H27ClN4O4 (470.17207320000006)
O-(3-O-D-galactosyl-N-acetyl-beta-D-galactosaminyl)-L-serine
A derivative of L-serine having a 3-O-D-galactosyl-N-acetyl-beta-D-galactosaminyl moiety attached to the side-chain oxygen.
(3E,5R)-5-[(1R,5R,6Z,9Z,13R,15R)-5-(acetyloxy)-10-chloro-6-methyl-3-oxo-2,14-dioxabicyclo[11.2.1]hexadeca-6,9-dien-15-yl]-5-hydroxy-3-methylpent-3-enoic acid
(6R,7R,8S)-N-(4-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-[2-(3-pyridinyl)ethynyl]phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C27H23FN4O3 (470.17540999999994)
(6R,7S,8S)-N-(4-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-[2-(3-pyridinyl)ethynyl]phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C27H23FN4O3 (470.17540999999994)
(6R,7R,8R)-N-(4-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-[2-(3-pyridinyl)ethynyl]phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C27H23FN4O3 (470.17540999999994)
(6S,7S,8S)-4-[1,3-benzodioxol-5-yl(oxo)methyl]-8-(hydroxymethyl)-7-[4-(3-methylphenyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C28H26N2O5 (470.18416260000004)
(3S)-2-tert-butylsulfinyl-3-(2-hydroxyethyl)-4-[3-(3-hydroxy-3-methylbut-1-ynyl)phenyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxylic acid
C25H30N2O5S (470.18753300000003)
(6S,7S,8S)-N-(4-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-[2-(3-pyridinyl)ethynyl]phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C27H23FN4O3 (470.17540999999994)
(6R,7S,8R)-N-(4-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-[2-(3-pyridinyl)ethynyl]phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C27H23FN4O3 (470.17540999999994)
(6S,7R,8S)-N-(4-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-[2-(3-pyridinyl)ethynyl]phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C27H23FN4O3 (470.17540999999994)
(6S,7S,8R)-N-(4-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-[2-(3-pyridinyl)ethynyl]phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C27H23FN4O3 (470.17540999999994)
(6S,7R,8R)-N-(4-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-[2-(3-pyridinyl)ethynyl]phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C27H23FN4O3 (470.17540999999994)
(6R,7R,8S)-4-[1,3-benzodioxol-5-yl(oxo)methyl]-8-(hydroxymethyl)-7-[4-(3-methylphenyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C28H26N2O5 (470.18416260000004)
(6S,7S,8R)-4-[1,3-benzodioxol-5-yl(oxo)methyl]-8-(hydroxymethyl)-7-[4-(3-methylphenyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C28H26N2O5 (470.18416260000004)
D-Galactosyl-3-(N-acetyl-beta-D-galactosaminyl)-L-serine
(2S)-3-(2-acetamido-2-deoxy-3-O-beta-D-galactopyranosyl-alpha-D-galactopyranosyloxy)-2-azaniumylpropanoate
FR177391
A 14-membered macrolide isolated from the Serratia liquefaciens and exhibits anti-hyperlipidemic activity.
O-(3-O-D-galactosyl-N-acetyl-beta-D-galactosaminyl)-L-serine zwitterion
Zwitterionic form of O-(3-O-D-galactosyl-N-acetyl-beta-D-galactosaminyl)-L-serine arising from transfer of a proton from the carboxy to the amino group; major species at pH 7.3.
O-(3-O-beta-D-galactosyl-N-acetyl-alpha-D-galactosaminyl)-L-serine zwitterion
An amino acid zwitterion that is the zwitterionic form of O-(3-O-beta-D-galactosyl-N-acetyl-alpha-D-galactosaminyl)-L-serine arising from transfer of a proton from the carboxy to the amino group; major species at pH 7.3.